These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17919858)

  • 41. Drug-excipient compatibility testing using a high-throughput approach and statistical design.
    Wyttenbach N; Birringer C; Alsenz J; Kuentz M
    Pharm Dev Technol; 2005; 10(4):499-505. PubMed ID: 16370179
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factorial design of experiment for stability studies in the development of a tablet formulation.
    El-Banna HM; Ismail AA; Gadalla MA
    Pharmazie; 1984 Mar; 39(3):163-5. PubMed ID: 6728887
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterisation of protein stability in rod-insert vaginal rings.
    Pattani A; Lowry D; Curran RM; McGrath S; Kett VL; Andrews GP; Malcolm RK
    Int J Pharm; 2012 Jul; 430(1-2):89-97. PubMed ID: 22486955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a rapidly dispersing tablet of a poorly wettable compound: formulation DOE and mechanistic study of effect of formulation excipients on wetting of celecoxib.
    He X; Barone MR; Marsac PJ; Sperry DC
    Int J Pharm; 2008 Apr; 353(1-2):176-86. PubMed ID: 18207339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form.
    Zannou EA; Ji Q; Joshi YM; Serajuddin AT
    Int J Pharm; 2007 Jun; 337(1-2):210-8. PubMed ID: 17296277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form.
    Wu Y; Dali M; Gupta A; Raghavan K
    Pharm Dev Technol; 2009; 14(5):556-64. PubMed ID: 19743950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A stability-indicating HPLC method for the determination of glucosamine in pharmaceutical formulations.
    Shao Y; Alluri R; Mummert M; Koetter U; Lech S
    J Pharm Biomed Anal; 2004 May; 35(3):625-31. PubMed ID: 15137989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of formulation and manufacturing variables that influence in vitro dissolution and in vivo bioavailability of propranolol hydrochloride tablets.
    Eddington ND; Ashraf M; Augsburger LL; Leslie JL; Fossler MJ; Lesko LJ; Shah VP; Rekhi GS
    Pharm Dev Technol; 1998 Nov; 3(4):535-47. PubMed ID: 9834957
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Solid state compatibility study and characterization of a novel degradation product of tacrolimus in formulation.
    Rozman Peterka T; Grahek R; Hren J; Bastarda A; Bergles J; Urleb U
    J Pharm Biomed Anal; 2015 Jun; 110():67-75. PubMed ID: 25804434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations.
    Kranz H; Wagner T
    Eur J Pharm Biopharm; 2006 Jan; 62(1):70-6. PubMed ID: 16154330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Application of HPLC to assess the compatibility of bisoprolol fumarate with selected excipients in mixtures by isothermal stress testing.
    Marothu VK; Yerramothu P; Gorrepati M; Majeti S; Mamidala SK; Nellutla A
    Ann Pharm Fr; 2015 Nov; 73(6):442-51. PubMed ID: 26142745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of formulation excipients on the stability of the novel antitumor agent carzelesin (U-80,244).
    Jonkman-De Vries JD; Rosing H; Henrar RE; Bult A; Beijnen JH
    PDA J Pharm Sci Technol; 1995; 49(6):283-8. PubMed ID: 8581459
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simultaneous Determination of Acetaminophen and Synthetic Color(s) by Derivative Spectroscopy in Syrup Formulations and Validation by HPLC: Exposure Risk of Colors to Children.
    Rastogi SD; Dixit S; Tripathi A; Das M
    AAPS PharmSciTech; 2015 Jun; 16(3):505-17. PubMed ID: 25374343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug-Excipient Compatibility Study Through a Novel Vial-in-Vial Experimental Setup: A Benchmark Study.
    Jain S; Shah RP
    AAPS PharmSciTech; 2023 May; 24(5):117. PubMed ID: 37160790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Using different experimental designs in drug-excipient compatibility studies during the preformulation development of a stable solid dosage formulation.
    Bohanec S; Peterka TR; Blažič P; Jurečič R; Grmaš J; Krivec A; Zakrajšek J
    Acta Chim Slov; 2010 Dec; 57(4):895-903. PubMed ID: 24061893
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new approach to accelerated drug-excipient compatibility testing.
    Sims JL; Carreira JA; Carrier DJ; Crabtree SR; Easton L; Hancock SA; Simcox CE
    Pharm Dev Technol; 2003; 8(2):119-26. PubMed ID: 12760562
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modernization of Physical Appearance and Solution Color Tests Using Quantitative Tristimulus Colorimetry: Advantages, Harmonization, and Validation Strategies.
    Pack BW; Montgomery LL; Hetrick EM
    J Pharm Sci; 2015 Oct; 104(10):3299-313. PubMed ID: 26173406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Color stability of tablet formulations. I. Measurement of changes in individual tablet reflectance.
    URBANYI T; SWARTZ CJ; LACHMAN L
    J Am Pharm Assoc Am Pharm Assoc; 1960 Mar; 49():163-4. PubMed ID: 13855182
    [No Abstract]   [Full Text] [Related]  

  • 60. Solid-state stability of aspirin in the presence of excipients: kinetic interpretation, modeling, and prediction.
    Mroso PV; Li Wan Po A; Irwin WJ
    J Pharm Sci; 1982 Oct; 71(10):1096-101. PubMed ID: 7143203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.